Immunoglobulin Disease
1 clinical trials · Condition
◉ Watch Immunoglobulin Disease
| Record | Firm | Date |
|---|---|---|
| Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. (NCT06858319) | Novartis Pharmaceuticals | 2025-07-28 |
Track Immunoglobulin Disease automatically
Every clearance here is in the API, with alerts when new ones post.